RESEARCH
Dexamethasone as An Adjuvant to Fascia Iliaca Compartment Block for Surgeries of Hip Fracture: A Systematic Review .
There is limited evidence for adding dexamethasone to fascia iliaca compartment block (FICB) in hip-fracture surgery; only four small RCTs exist, and they’re too heterogeneous for a pooled analysis. Across studies, dexamethasone consistently improved analgesia-related outcomes: patients needed fewer rescue medications, went longer before requesting them, and experienced longer block duration. Safety signals were reassuring, with no increase in adverse events. But when it comes to pain scores themselves, results were mixed—two trials showed no meaningful difference compared with FICB alone. Overall, the early data look promising for enhanced analgesia, but the evidence base is thin, methods are inconsistent, and stronger, well-designed RCTs are needed before making firm clinical recommendations.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
